InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-25)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

US US6,790 companies

US-Listed Companies

Regulator: SEC (Form 4).

Lawson Products Inc/new

Finance & Banque · 4.5bn

Lazydays Holdings, Inc.

Distribution & Commerce

Leader Capital Holdings Corp.

Technologie · 859k

Leader Capital Holdings Corp.

Finance & Banque · 103m

Leaf Group Ltd.

Médias & Communication

Leafly Holdings, Inc. /DE

Médias & Communication

Leap Therapeutics, INC.

Santé & Pharma

Learn CW Investment Corp

Industrie · 76m

Legacy Education Alliance, Inc.

← PreviousPage 74 of 136Next →

Agroalimentaire · 492

Legacy Housing Corp

Construction & BTP · 465m

Legalzoom.com, INC.

Services aux entreprises · 1bn

Legato Merger CORP. II

Legato Merger Corp.

Leggett & Platt INC

Industrie · 1.3bn

Leidos Holdings, Inc.

Défense & Aérospatial · 16bn

Lemaitre Vascular INC

Santé & Pharma · 1.8bn

Assurance · 3.9bn

LendingClub Corp

Finance & Banque · 1.8bn

LendingTree, Inc.

Finance & Banque · 731m

Lennar CORP /new/

Construction & BTP

Lennox International INC

Industrie · 17bn

Leonardo DRS, Inc.

Défense & Aérospatial · 11bn

Distribution & Commerce · 51m

Level One Bancorp Inc

Finance & Banque

Levi Strauss & Co

Luxe & Mode · 8.6bn

Lexaria Bioscience Corp.

Healthcare · 14m

Lexicon Pharmaceuticals, INC.

Healthcare · 944m

Lexington Realty Trust

Immobilier · 3bn

Lftd Partners INC.

Distribution & Commerce · 2.8m

Santé & Pharma · 178m

Liberated Syndication Inc.

Médias & Communication

Liberty ALL Star Equity Fund

Finance & Banque · 1.9bn

Liberty ALL Star Growth Fund INC.

Finance & Banque · 325m

Liberty Broadband Corp

Médias & Communication

Liberty Energy Inc.

Énergie · 3bn

Liberty Global plc

Médias & Communication · 3.7bn

Liberty Latin America Ltd.

Médias & Communication · 1.5bn

Liberty Media Corp

Médias & Communication · 21bn

Liberty Oilfield Services Inc.

Énergie · 5.4bn

Liberty Star Uranium & Metals CORP.

Chimie & Matériaux · 2.9m

Liberty TripAdvisor Holdings, Inc.

Tourisme & Hôtellerie

Life Storage, INC.

Life Time Group Holdings, Inc.

Tourisme & Hôtellerie · 7.5bn

Technologie · 3.1bn

Santé & Pharma · 164m

Santé & Pharma · 164m

LifeStance Health Group, Inc.

Santé & Pharma · 2.7bn

LifeStance Health Group, Inc.

Santé & Pharma · 2.9bn